Skip to search.
 TSX Up 0.17% TSX Ventures Up 1.33%

Eli Lilly and Company (LLY)

-NYSE
67.71 Up 1.74(2.64%) Dec 2, 4:03PM EST
|After Hours : 67.70 Down 0.01 (0.01%) Dec 2, 7:58PM EST
Prev Close:65.97
Open:66.30
Bid:67.61 x 100
Ask:67.70 x 200
1y Target Est:85.38
Beta:0.218617
Next Earnings Date:31-Jan-17LLY Earnings announcement
Day's Range:65.96 - 68.39
52wk Range:64.18 - 88.16
Volume:12,272,207
Avg Vol (3m):5,327,550
Market Cap:71.45B
P/E (ttm):29.45
EPS (ttm):2.30
Div & Yield:2.04 (3.04%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LLYUp 2.64%71.45B
GSKUp 0.72%93.89B
PFEUp 0.54%191.94B

Key Statistics

Forward P/E (1 yr):17.06
P/S (ttm):3.35
Ex-Dividend Date:11-Nov-16

Analysts

Annual EPS Est (Dec-16) :3.52
Quarterly EPS Est (Dec-16) :0.95
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.90

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback